JPRN-jRCT2080220107未知2 期
Phase II study on NKT-01 in patients with refractory Wegener's granulomatosis
ippon Kayaku Co., Ltd.0 个研究点开始时间: 2005年9月12日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 80age old（—）
- 性别
- All
入选标准
- •Inclusion Criteria:
- •Diagnosis of Wegener's granulomatosis according to the ACR criteria and the Chapel Hill Consensus Conference definition; BVAS >= 4; Treatment duration >= 3 months with CYC or >= 6 months with MTX; Age between 18 and 80 years; WBC >= 4,000/mm3.
排除标准
- •Pregnant or nursing mothers and women of childbearing age; Active bacterial/viral infection; History of HIV infection or active HBV or HCV infection.
研究者
相似试验
进行中（未招募）
2 期
Phase IIb/III Clinical Study of CNT-01 in Patients with Idiopathic Triglyceride Deposit CardiomyovasculopathyIdiopathic triglyceride deposit cardiomyovasculopathyJPRN-jRCT2051210177Akita Yasuhiko60
未知
1 期
Phase I/II study of NK012Multiple myelomaJPRN-jRCT2080221611ippon Kayaku Co., Ltd.60
已完成
1 期
Phase I/IIa Study of CNT-01 in Patients with Idiopathic Triglyceride Deposit CardiomyovasculopathyIdiopathic Triglyceride Deposit CardiomyovasculopathyJPRN-UMIN000018289Ken-ichi Hirano, Department of Cardiovascular Medicine, Osaka University Grduate School of Medicine6
未知
2 期
Phase II clinical study of TY-0201 in patients with chronic heart failureChronic heart failureJPRN-jRCT2080222593TOA EIYO LTD.40
招募中
2 期
Phase IIa trial of CNT-01 for patients with idiopathic triglyceride deposit cardiomyovasculopathy.JPRN-UMIN000035403Osaka university hospital20